MHUAF MEIHUA INTERNATIONAL MEDICAL TECHNOLOGIES cO., LTD.
Fundamentals / CIK 0001835615 / USDMEIHUA INTERNATIONAL MEDICAL TECHNOLOGIES cO., LTD. reported $61.79M in revenue and net income of $6.78M for the fiscal year ended December 31, 2025 (down 36.2% year over year), with a 31.0% gross margin and a 13.4% operating margin.
Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open MHUAF in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.
-
Revenue FY 2025$61.79M -36.2% YoY
-
Operating Income FY 2025$8.28M 13.4% margin
-
Net Income FY 2025$6.78M 11.0% net margin
-
Diluted EPS FY 2025$18.04 Split-adjusted
-
Free Cash Flow FY 2025$554K 0.9% FCF margin
-
Cash & ST Investments Dec 31, 2025$15.15M Total debt: $8.99M
Annual revenue and net income
7 fiscal years (2019 to 2025), reported in USD.
Financial statements and ratios
Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.
Income Statement (Annual) · Reported in USD · Newest filing period first.
| Income Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|
| Revenue | $61.79M | $96.91M | $97.10M | $103.3M | $104.0M | $89.06M | $79.63M |
| Cost of Revenue | $42.63M | $63.61M | $63.90M | $65.25M | $64.23M | $51.90M | $47.42M |
| Gross Profit | $19.16M | $33.30M | $33.20M | $38.10M | $39.81M | $37.16M | $32.21M |
| Research & Development | $2.38M | $3.46M | $2.75M | $2.96M | $2.73M | $2.49M | $3.21M |
| Selling, General & Admin | $7.44M | $14.42M | $13.84M | $19.58M | $10.82M | $11.20M | $9.61M |
| Total Operating Expenses | $10.88M | $18.99M | $18.52M | $27.30M | $13.54M | $13.69M | $12.82M |
| Operating Income | $8.28M | $14.31M | $14.67M | $10.80M | $26.26M | $23.47M | $19.39M |
| EBITDA | $8.83M | $14.88M | $15.15M | $11.34M | $26.86M | $23.96M | $19.87M |
| Interest Income | $1.26M | $1.01M | $873K | $64K | $24K | -- | -- |
| Interest Expense | $242K | $1.51M | $251K | $191K | $181K | $137K | $98K |
| Income Before Tax | $9.41M | $13.63M | $15.05M | $10.89M | $26.23M | $23.73M | $19.25M |
| Income Tax Expense | $2.62M | $2.79M | $3.46M | $4.71M | $5.28M | $4.69M | $3.82M |
| Net Income | $6.78M | $10.84M | $11.63M | $6.24M | $20.95M | $19.05M | $15.43M |
| Basic EPS | $18.04 | $39.62 | $48.56 | $27.00 | $105.00 | $95.00 | $83.00 |
| Diluted EPS | $18.04 | $39.62 | $48.56 | $27.00 | $105.00 | $95.00 | -- |
| Basic Shares Outstanding | 376.0K | 273.7K | 239.4K | 234.1K | 200.0K | 200.0K | 185.8K |
| Diluted Shares Outstanding | 376.0K | 273.7K | 239.4K | 234.1K | 200.0K | 200.0K | -- |
Income Statement (Quarterly) · Reported in USD · Newest filing period first.
Balance Sheet (Annual) · Reported in USD · Newest filing period first.
| Balance Sheet | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $15.15M | $15.96M | $16.93M | $26.74M | $8.15M | $7.19M |
| Cash & Short-Term Investments | $15.15M | $15.96M | $16.93M | $26.74M | $8.15M | $7.19M |
| Accounts Receivable, Net | $84.33M | $78.66M | $78.57M | $68.95M | $67.10M | $45.70M |
| Inventory | $1.70M | $1.41M | $1.62M | $1.12M | $1.25M | $1.33M |
| Total Current Assets | $153.6M | $143.4M | $132.2M | $135.3M | $97.28M | $67.57M |
| Property, Plant & Equipment, Net | $7.70M | $7.89M | $8.83M | $8.76M | $7.48M | $7.10M |
| Goodwill | -- | $7.90M | -- | -- | -- | -- |
| Intangible Assets | $446K | $443K | $3.92M | $498K | $562K | $576K |
| Long-Term Investments | $23.45M | $22.39M | $6.13M | $6.67M | $942K | $920K |
| Other Non-Current Assets | $22.00M | $11.09M | $11.27M | $12.33M | -- | -- |
| Total Non-Current Assets | $53.60M | $42.80M | $39.68M | $28.26M | $39.58M | $38.48M |
| Total Assets | $207.2M | $186.2M | $171.9M | $163.6M | $136.9M | $106.0M |
| Accounts Payable | $8.42M | $15.48M | $15.82M | $16.10M | $20.98M | $15.64M |
| Short-Term Debt | $8.99M | $7.95M | $7.32M | $6.09M | $5.18M | $3.22M |
| Total Current Liabilities | $18.25M | $27.26M | $25.07M | $24.17M | $29.09M | $21.31M |
| Long-Term Debt | -- | -- | -- | $725K | -- | -- |
| Total Non-Current Liabilities | $0 | $0 | $4.6K | $725K | $0 | $0 |
| Total Liabilities | $18.25M | $27.26M | $25.08M | $24.90M | $29.09M | $21.31M |
| Total Debt (incl. Leases) | $8.99M | $7.95M | $7.33M | $6.81M | $5.18M | $3.22M |
| Common Stock | -- | $16K | $12K | $12K | $10K | $10K |
| Retained Earnings | $111.9M | $105.2M | $94.64M | $83.33M | $77.57M | $56.63M |
| Accumulated Other Comp. Income | -$4.87M | -$11.53M | -$7.27M | -$3.85M | $5.29M | $3.21M |
| Total Stockholders' Equity | $188.9M | $159.0M | $146.3M | $138.1M | $107.8M | $84.74M |
| Total Equity | $188.9M | $159.0M | $146.8M | $138.7M | $107.8M | $84.74M |
Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.
| Balance Sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $15.15M | $15.96M | $16.93M | $26.74M | $8.15M | $7.19M |
| Cash & Short-Term Investments | $15.15M | $15.96M | $16.93M | $26.74M | $8.15M | $7.19M |
| Accounts Receivable, Net | $84.33M | $78.66M | $78.57M | $68.95M | $67.10M | $45.70M |
| Inventory | $1.70M | $1.41M | $1.62M | $1.12M | $1.25M | $1.33M |
| Total Current Assets | $153.6M | $143.4M | $132.2M | $135.3M | $97.28M | $67.57M |
| Property, Plant & Equipment, Net | $7.70M | $7.89M | $8.83M | $8.76M | $7.48M | $7.10M |
| Goodwill | -- | $7.90M | -- | -- | -- | -- |
| Intangible Assets | $446K | $443K | $3.92M | $498K | $562K | $576K |
| Long-Term Investments | $23.45M | $22.39M | $6.13M | $6.67M | $942K | $920K |
| Other Non-Current Assets | $22.00M | $11.09M | $11.27M | $12.33M | -- | -- |
| Total Non-Current Assets | $53.60M | $42.80M | $39.68M | $28.26M | $39.58M | $38.48M |
| Total Assets | $207.2M | $186.2M | $171.9M | $163.6M | $136.9M | $106.0M |
| Accounts Payable | $8.42M | $15.48M | $15.82M | $16.10M | $20.98M | $15.64M |
| Short-Term Debt | $8.99M | $7.95M | $7.32M | $6.09M | $5.18M | $3.22M |
| Total Current Liabilities | $18.25M | $27.26M | $25.07M | $24.17M | $29.09M | $21.31M |
| Long-Term Debt | -- | -- | -- | $725K | -- | -- |
| Total Non-Current Liabilities | $0 | $0 | $4.6K | $725K | $0 | $0 |
| Total Liabilities | $18.25M | $27.26M | $25.08M | $24.90M | $29.09M | $21.31M |
| Total Debt (incl. Leases) | $8.99M | $7.95M | $7.33M | $6.81M | $5.18M | $3.22M |
| Common Stock | -- | $16K | $12K | $12K | $10K | $10K |
| Retained Earnings | $111.9M | $105.2M | $94.64M | $83.33M | $77.57M | $56.63M |
| Accumulated Other Comp. Income | -$4.87M | -$11.53M | -$7.27M | -$3.85M | $5.29M | $3.21M |
| Total Stockholders' Equity | $188.9M | $159.0M | $146.3M | $138.1M | $107.8M | $84.74M |
| Total Equity | $188.9M | $159.0M | $146.8M | $138.7M | $107.8M | $84.74M |
Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.
| Cash Flow Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|
| Net Income | $6.78M | $10.84M | $11.59M | $6.18M | $20.95M | $19.05M | $15.43M |
| Depreciation & Amortization | $549K | $571K | $470K | $541K | $596K | $497K | $481K |
| Change in Receivables | -$3.26M | -$4.25M | -$13.56M | -$7.12M | -$20.07M | -$13.64M | -$4.71M |
| Change in Inventory | -$227K | $166K | -$529K | $35K | $105K | -$220K | $803K |
| Change in Payables | -$7.48M | $932K | $186K | -$3.37M | $4.91M | $5.34M | -$4.23M |
| Operating Cash Flow | $570K | $14.64M | $2.28M | -$9.16M | -$55K | $5.33M | $9.31M |
| Capital Expenditure | -$16K | -$134K | -$1.18M | -$2.70M | -$850K | -$3.81M | -$267K |
| Free Cash Flow | $554K | $14.50M | $1.09M | -$11.86M | -$905K | $1.52M | $9.04M |
| Sales & Maturities of Investments | -- | $1.39M | $706K | -- | -- | -- | -- |
| Investing Cash Flow | -$20.13M | -$20.42M | -$12.46M | -$8.62M | -$834K | -$16.09M | -$8.90M |
| Common Stock Issued | -- | -- | -- | -- | -- | -- | $345K |
| Share Repurchases | -- | -$200K | -- | -- | -- | -- | -- |
| Financing Cash Flow | $17.19M | $6.21M | $706K | $37.25M | $1.86M | $1.71M | $924K |
| Net Change in Cash | -$2.14M | $362K | -$9.81M | $18.59M | $962K | -$8.84M | $1.23M |
Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.
Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.
| Ratios & Growth | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|
| Gross Margin | 31.0% | 34.4% | 34.2% | 36.9% | 38.3% | 41.7% | 40.5% |
| Operating Margin | 13.4% | 14.8% | 15.1% | 10.5% | 25.2% | 26.3% | 24.3% |
| Net Profit Margin | 11.0% | 11.2% | 12.0% | 6.0% | 20.1% | 21.4% | 19.4% |
| Return on Equity (ROE) | 3.6% | 6.8% | 7.9% | 4.5% | 19.4% | 22.5% | -- |
| Return on Assets (ROA) | 3.3% | 5.8% | 6.8% | 3.8% | 15.3% | 18.0% | -- |
| Current Ratio | 8.42x | 5.26x | 5.27x | 5.60x | 3.34x | 3.17x | -- |
| Quick Ratio | 8.32x | 5.21x | 5.21x | 5.55x | 3.30x | 3.11x | -- |
| Debt to Equity | 0.05x | 0.05x | 0.05x | 0.05x | 0.05x | 0.04x | -- |
| Revenue Growth (YoY) | -36.2% | -0.2% | -6.0% | -0.7% | +16.8% | +11.8% | -- |
| Gross Profit Growth (YoY) | -42.5% | +0.3% | -12.9% | -4.3% | +7.1% | +15.4% | -- |
| Operating Income Growth (YoY) | -42.1% | -2.5% | +35.9% | -58.9% | +11.9% | +21.0% | -- |
| Net Income Growth (YoY) | -37.5% | -6.7% | +86.2% | -70.2% | +10.0% | +23.4% | -- |
| EPS Growth (YoY) | -54.5% | -18.4% | +79.9% | -74.3% | +10.5% | +14.5% | -- |
| Operating Cash Flow Growth (YoY) | -96.1% | +543.2% | -- | -- | -101.0% | -42.8% | -- |
| Free Cash Flow Growth (YoY) | -96.2% | +1226.9% | -- | -- | -159.6% | -83.2% | -- |
| 5Y Revenue / Share Growth | -63.1% | -17.4% | -- | -- | -- | -- | -- |
| 5Y Net Income / Share Growth | -81.1% | -52.3% | -- | -- | -- | -- | -- |
Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.